Virtu Financial LLC Takes Position in Henry Schein, Inc. (NASDAQ:HSIC)

Virtu Financial LLC bought a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the third quarter, HoldingsChannel reports. The fund bought 3,283 shares of the company’s stock, valued at approximately $239,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. TCW Group Inc. raised its stake in shares of Henry Schein by 6.6% in the third quarter. TCW Group Inc. now owns 26,368 shares of the company’s stock worth $1,922,000 after buying an additional 1,628 shares during the period. Toronto Dominion Bank increased its holdings in Henry Schein by 68.3% in the 3rd quarter. Toronto Dominion Bank now owns 62,779 shares of the company’s stock worth $4,577,000 after acquiring an additional 25,474 shares in the last quarter. M&T Bank Corp raised its stake in Henry Schein by 4.5% during the 3rd quarter. M&T Bank Corp now owns 10,990 shares of the company’s stock worth $802,000 after acquiring an additional 472 shares during the period. Barclays PLC lifted its holdings in Henry Schein by 6.9% during the third quarter. Barclays PLC now owns 286,475 shares of the company’s stock valued at $20,882,000 after purchasing an additional 18,458 shares in the last quarter. Finally, Nomura Asset Management Co. Ltd. boosted its position in shares of Henry Schein by 1.0% in the third quarter. Nomura Asset Management Co. Ltd. now owns 38,816 shares of the company’s stock worth $2,830,000 after purchasing an additional 373 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 1.14% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the topic of several recent analyst reports. Evercore ISI raised their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho assumed coverage on Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. Finally, Barrington Research reissued an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. Seven investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $78.89.

Henry Schein Price Performance

Shares of Henry Schein stock opened at $73.18 on Wednesday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.63. The stock has a 50 day moving average of $72.36 and a 200 day moving average of $70.10. The firm has a market cap of $9.12 billion, a PE ratio of 30.12, a PEG ratio of 2.31 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the company earned $1.32 EPS. The company’s quarterly revenue was up .4% compared to the same quarter last year. On average, research analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.